Overactive Bladder (OAB) Therapeutics Market Report

Global and China Overactive Bladder (OAB) Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Oct 31, 2022
  • PAGES：161
  • REPORT CODE：GMM1331349
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Overactive Bladder (OAB) Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Teva Pharmaceutical Industries 

    • Ferring 

    • Allergan 

    • Pfizer 

    • Kwang Dong Pharmaceutical 

    • ONO Pharmaceutical 

    • Astellas Pharma 

    • Ion Channel Innovations 

    • Hisamitsu Pharmaceutical 

    • Urovant Sciences

    • GSK

    • Merck 

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Anticholinergic Agents

    • Beta-3 Adrenoreceptor Agonists

    Application:

    • Hosptial

    • Clinci

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Overactive Bladder (OAB) Therapeutics Industry Overview

      • 1.1.1 Overactive Bladder (OAB) Therapeutics Market Scope and Market Segments

      • 1.1.2 Overactive Bladder (OAB) Therapeutics Industry Characteristics

      • 1.1.3 Global and China Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Overactive Bladder (OAB) Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Anticholinergic Agents

      • 1.2.2 Beta-3 Adrenoreceptor Agonists

    • 1.3 Global Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hosptial

      • 1.3.2 Clinci

      • 1.3.3 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Overactive Bladder (OAB) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Overactive Bladder (OAB) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Overactive Bladder (OAB) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Overactive Bladder (OAB) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Overactive Bladder (OAB) Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Overactive Bladder (OAB) Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Overactive Bladder (OAB) Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Overactive Bladder (OAB) Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Overactive Bladder (OAB) Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Overactive Bladder (OAB) Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Overactive Bladder (OAB) Therapeutics Industry PEST Analysis

    • 2.3 Overactive Bladder (OAB) Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Overactive Bladder (OAB) Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Overactive Bladder (OAB) Therapeutics Industry

    Chapter 3 Global and China Overactive Bladder (OAB) Therapeutics Market, by Manufacturer

    • 3.1 Global and China Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Overactive Bladder (OAB) Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Overactive Bladder (OAB) Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Overactive Bladder (OAB) Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Overactive Bladder (OAB) Therapeutics Market Top 3 Players

    Chapter 4 Global and China Overactive Bladder (OAB) Therapeutics Market, by Type (2017-2028)

    • 4.1 Overactive Bladder (OAB) Therapeutics Market Trend, by Type

    • 4.2 Global Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Overactive Bladder (OAB) Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Overactive Bladder (OAB) Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Overactive Bladder (OAB) Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Overactive Bladder (OAB) Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Overactive Bladder (OAB) Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Overactive Bladder (OAB) Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Overactive Bladder (OAB) Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Overactive Bladder (OAB) Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Overactive Bladder (OAB) Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Overactive Bladder (OAB) Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Overactive Bladder (OAB) Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Overactive Bladder (OAB) Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Overactive Bladder (OAB) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Overactive Bladder (OAB) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Overactive Bladder (OAB) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Overactive Bladder (OAB) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Overactive Bladder (OAB) Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Overactive Bladder (OAB) Therapeutics Market Analysis

    • 7.1 North America Overactive Bladder (OAB) Therapeutics Market, by Type

    • 7.2 North America Overactive Bladder (OAB) Therapeutics Market, by Application

    • 7.3 North America Overactive Bladder (OAB) Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Overactive Bladder (OAB) Therapeutics Market Analysis

    • 8.1 Europe Overactive Bladder (OAB) Therapeutics Market, by Type

    • 8.2 Europe Overactive Bladder (OAB) Therapeutics Market, by Application

    • 8.3 Europe Overactive Bladder (OAB) Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Overactive Bladder (OAB) Therapeutics Market Analysis

    • 9.1 APAC Overactive Bladder (OAB) Therapeutics Market, by Type

    • 9.2 APAC Overactive Bladder (OAB) Therapeutics Market, by Application

    • 9.3 APAC Overactive Bladder (OAB) Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Overactive Bladder (OAB) Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa Overactive Bladder (OAB) Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa Overactive Bladder (OAB) Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa Overactive Bladder (OAB) Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Overactive Bladder (OAB) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Overactive Bladder (OAB) Therapeutics Company Profiles

      • 11.1 Teva Pharmaceutical Industries 

        • 11.1.1 Teva Pharmaceutical Industries  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Teva Pharmaceutical Industries  Overactive Bladder (OAB) Therapeutics Product Profiles, Application and Specification

        • 11.1.3 Teva Pharmaceutical Industries  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Ferring 

        • 11.2.1 Ferring  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Ferring  Overactive Bladder (OAB) Therapeutics Product Profiles, Application and Specification

        • 11.2.3 Ferring  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Allergan 

        • 11.3.1 Allergan  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Allergan  Overactive Bladder (OAB) Therapeutics Product Profiles, Application and Specification

        • 11.3.3 Allergan  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Pfizer 

        • 11.4.1 Pfizer  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Pfizer  Overactive Bladder (OAB) Therapeutics Product Profiles, Application and Specification

        • 11.4.3 Pfizer  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Kwang Dong Pharmaceutical 

        • 11.5.1 Kwang Dong Pharmaceutical  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Kwang Dong Pharmaceutical  Overactive Bladder (OAB) Therapeutics Product Profiles, Application and Specification

        • 11.5.3 Kwang Dong Pharmaceutical  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 ONO Pharmaceutical 

        • 11.6.1 ONO Pharmaceutical  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 ONO Pharmaceutical  Overactive Bladder (OAB) Therapeutics Product Profiles, Application and Specification

        • 11.6.3 ONO Pharmaceutical  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Astellas Pharma 

        • 11.7.1 Astellas Pharma  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Astellas Pharma  Overactive Bladder (OAB) Therapeutics Product Profiles, Application and Specification

        • 11.7.3 Astellas Pharma  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Ion Channel Innovations 

        • 11.8.1 Ion Channel Innovations  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Ion Channel Innovations  Overactive Bladder (OAB) Therapeutics Product Profiles, Application and Specification

        • 11.8.3 Ion Channel Innovations  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Hisamitsu Pharmaceutical 

        • 11.9.1 Hisamitsu Pharmaceutical  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Hisamitsu Pharmaceutical  Overactive Bladder (OAB) Therapeutics Product Profiles, Application and Specification

        • 11.9.3 Hisamitsu Pharmaceutical  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Urovant Sciences

        • 11.10.1 Urovant Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Urovant Sciences Overactive Bladder (OAB) Therapeutics Product Profiles, Application and Specification

        • 11.10.3 Urovant Sciences Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 GSK

        • 11.11.1 GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 GSK Overactive Bladder (OAB) Therapeutics Product Profiles, Application and Specification

        • 11.11.3 GSK Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Merck 

        • 11.12.1 Merck  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Merck  Overactive Bladder (OAB) Therapeutics Product Profiles, Application and Specification

        • 11.12.3 Merck  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Overactive Bladder (OAB) Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 Overactive Bladder (OAB) Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Overactive Bladder (OAB) Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Overactive Bladder (OAB) Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China Overactive Bladder (OAB) Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate of Anticholinergic Agents (2017-2028)

    • Figure Global Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate of Beta-3 Adrenoreceptor Agonists (2017-2028)

    • Figure Global Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate of Hosptial (2017-2028)

    • Figure Global Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate of Clinci (2017-2028)

    • Figure Global Overactive Bladder (OAB) Therapeutics Market Size and Growth Rate of Other (2017-2028)

    • Figure North America Overactive Bladder (OAB) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Overactive Bladder (OAB) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Overactive Bladder (OAB) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Overactive Bladder (OAB) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Overactive Bladder (OAB) Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Overactive Bladder (OAB) Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Overactive Bladder (OAB) Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Overactive Bladder (OAB) Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Overactive Bladder (OAB) Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Overactive Bladder (OAB) Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China Overactive Bladder (OAB) Therapeutics Market Share, by Manufacturer in 2022

    • Table Global Overactive Bladder (OAB) Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global Overactive Bladder (OAB) Therapeutics Sales Value, by Type (2017-2028)

    • Table Global Overactive Bladder (OAB) Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global Overactive Bladder (OAB) Therapeutics Price Trend, by Type (2017-2028)

    • Table China Overactive Bladder (OAB) Therapeutics Sales Volume, by Type (2017-2028)

    • Table China Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China Overactive Bladder (OAB) Therapeutics Sales Value, by Type (2017-2028)

    • Table China Overactive Bladder (OAB) Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China Overactive Bladder (OAB) Therapeutics Price Trend, by Type (2017-2028)

    • Table Global Overactive Bladder (OAB) Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global Overactive Bladder (OAB) Therapeutics Sales Value, by Application (2017-2028)

    • Table Global Overactive Bladder (OAB) Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global Overactive Bladder (OAB) Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China Overactive Bladder (OAB) Therapeutics Sales Volume, by Application (2017-2028)

    • Table China Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China Overactive Bladder (OAB) Therapeutics Sales Value, by Application (2017-2028)

    • Table China Overactive Bladder (OAB) Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Overactive Bladder (OAB) Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Overactive Bladder (OAB) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Overactive Bladder (OAB) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Overactive Bladder (OAB) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Overactive Bladder (OAB) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Overactive Bladder (OAB) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America Overactive Bladder (OAB) Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America Overactive Bladder (OAB) Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe Overactive Bladder (OAB) Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe Overactive Bladder (OAB) Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC Overactive Bladder (OAB) Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC Overactive Bladder (OAB) Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Overactive Bladder (OAB) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Overactive Bladder (OAB) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Overactive Bladder (OAB) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Teva Pharmaceutical Industries  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Pharmaceutical Industries  Product Profiles, Application and Specification

    • Table Teva Pharmaceutical Industries  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ferring  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ferring  Product Profiles, Application and Specification

    • Table Ferring  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Allergan  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Allergan  Product Profiles, Application and Specification

    • Table Allergan  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer  Product Profiles, Application and Specification

    • Table Pfizer  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kwang Dong Pharmaceutical  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kwang Dong Pharmaceutical  Product Profiles, Application and Specification

    • Table Kwang Dong Pharmaceutical  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ONO Pharmaceutical  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ONO Pharmaceutical  Product Profiles, Application and Specification

    • Table ONO Pharmaceutical  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma  Product Profiles, Application and Specification

    • Table Astellas Pharma  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ion Channel Innovations  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ion Channel Innovations  Product Profiles, Application and Specification

    • Table Ion Channel Innovations  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hisamitsu Pharmaceutical  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hisamitsu Pharmaceutical  Product Profiles, Application and Specification

    • Table Hisamitsu Pharmaceutical  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Urovant Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Urovant Sciences Product Profiles, Application and Specification

    • Table Urovant Sciences Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GSK Product Profiles, Application and Specification

    • Table GSK Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck  Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck  Product Profiles, Application and Specification

    • Table Merck  Overactive Bladder (OAB) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US